AllStent team
The AllStent team has >50-years experience in numerical modelling through global collaborations with leading vascular surgeons and stent-graft manufacturers. Additionally, we have deep expertise in Medtech start-up financing and commercialization, and are pursuing US and EU regulatory clearances.
For more details please contact ceo@allstent.com.
SARA BARATI
Founder & AI/ML Development Scientific Advisor
Dr. Sara Barati is a post-doctoral researcher at the Politecnico di Milano (Italy), specializing in the integration of artificial intelligence into cardiovascular engineering applications. She holds a Ph.D. in Biomedical Engineering-Biomechanics from the Amirkabir University of Technology (Tehran Polytechnic). Her Ph.D. thesis focused on the design optimization of transcatheter aortic valve stents and was conducted in collaboration with the Laboratory of Biological Structure Mechanics at Politecnico di Milano. This work earned her the 2022 Best Thesis Award from the Iranian Society of Biomedical Engineering. Dr. Barati has extensive expertise in FEA, CFD, FSI, and optimization techniques. Additionally, she leverages machine learning to advance her research in cardiovascular engineering developing in-house codes for biomechanical analysis of different cardiovascular problems. Her professional experience includes the design, testing, and optimization of medical devices. She has collaborated with biomedical engineering start-ups, the healthcare industry, and multidisciplinary academic research teams on various projects.
ANNA RAMELLA
Founder & Simulation Development Scientific Advisor
Anna Ramella is currently pursuing her PhD in Bioengineering at Politecnico di Milano (Italy). With more then 4 years of experience stent-graft modelling, Anna has developed an innovative numerical method for replicating TEVAR. Her strong background in numerical simulation and expertise in FEA, CFD, FSI analysis has been fundamental to her success. Recognized for her significant contributions to the field, among the others, Anna won the 2024 Clinical Biomechanics Award (by the European Society of Biomechanics) and the 2023 Researcher Prize at the European Symposium on Vascular Biomaterials. Her research is supported by strong collaborations with clinicians both nationally and internationally. These partnerships have been crucial in advancing her work and driving improvements in modeling medical devices and endovascular interventions. Anna's dedication to bridging the gap between engineering and clinical practice continues to make a significant impact in this field.
GIULIA LURAGHI
Founder & Scientific Advisor
Dr. Giulia Luraghi is currently Assistant Professor at Politecnico di Milano (Italy), leading the Cardiovascular section of the Computational Biomechanics Laboratory & In Silico Medicine. She is Affiliated Research fellow at the Department of Biomechanical Engineering, Delft University of Technology (Netherlands). Her expertise is in FEA, CFD, and FSI modeling and machine learning applied to cardiovascular applications. She is currently focusing on cardio/neurovascular minimally invasive procedures as TAVI, TEVAR, and intra-arterial thrombectomy for acute ischemic stroke. She won the 2024 Early Career Researcher Award (by the European Society of Biomechanics), the 2019 best Thematic Presentation for an in silico model (by the Italian chapter of the European Society of Biomechanics) and the best VPHi Student Award for the oral presentation (by the Virtual Physiological Human society). She is the PI at Politecnico di Milano of a European Union’s Horizon 2023 project. She is Executive Board member of the Italian chapter of the European Society of Biomechanics since 2023.
GEORGIANA OLTEANU
Founder & Product Manager
Georgiana Olteanu is a MSc Biomedical Engineer graduated at Politecnico di Milano, with a BSc in Medical Engineering from University Politehnica of Bucharest (Romania), focused on the commercialization and innovation of the healthcare ecosystem. Specialized in Information Bioengineering, she has been the Founders Associate Intern for a thriving digital health start-up for one year, where she supported the executives in business strategy, market analysis, product management and operations. She acquired diverse experience as an intern in the Central Military Emergency Hospital of Bucharest, Medical Device Acquisition Department and in University College London, Medical Physics and Biomedical Engineering Department, cultivating a comprehensive overview of the healthcare ecosystem, from start-up, public health and academic research point of views. Her entrepreneurial spirit was enhanced within Hackathon Competitions and industry event participations.
PAUL CHIPPERTON
Founder & CEO
A 30-year veteran of founding, raising capital and running life science start-ups, Paul formerly co-founded and led award-winning Prostate Cancer MedDev company Profound Medical Inc. (NASDAQ:PROF), and recently led Insight Medbotics Inc. through its most recent financing and FDA clearance. He is currently a board member of Fero International, and serves as a community rep on an Ontario Provincial Police (OPP) detachment board. He has served as a Chair or member of multiple other boards, including Angel Investors Ontario (AIO) and Northeastern University (USA) Program Advisory Committee. Part-time, he lectures MBA/MEEI/MHSc level courses at University of Toronto, Queen's, McMaster, Politecnico di Milano, and WU-Vienna on the topics of strategic innovation, venture capital finance and marketing, and has served an elected term as a Senator on Queen's University Senate.
FRANCESCO MIGLIAVACCA
Founder & Scientific Advisor
Prof. Francesco Migliavacca is Full Professor at Politecnico di Milano (Italy). He has 30-years experience in modelling medical devices. He has been pioneering patient-specific modelling in congenital and adult cardiac diseases. One of the first researcher coupling different scales to study hemodynamics in great vessels and modelling the first finite element models of coronary stents and percutaneous pulmonary valves. He has been research affiliate at MIT and research fellow at Great Ormond Street Hospital for Children in London, UK. For Politecnico di Milano he has been coordinator of research programs funded by European Union, Fondation Leducq and Italian Ministry of University. Consultant for high-tech companies.
SANTI TRIMARCHI
CAB Chair
Prof. Santi Trimarchi, MD, PhD is Full Professor of Vascular Surgery at Università degli Studi di Milano, and he is Head of the Vascular Surgery Unit at Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico in Milan (Italy). Through 30-years of career, his clinical-surgical and research activity focuses on the study and treatment of aortic diseases, including primarily aneurysms and dissections, but also of many other vascular diseases such as carotid stenosis, arteriopathies of the lower limbs and superficial and deep venous pathologies. To date he has performed more than 4000 operations. Extensive trans-atlantic experience has materialised through additional research and scholarly activities at Utrecht University, Holland; and Yale University, University of Michigan, University of Florida-Gainesville, and Harvard Medical School, USA. In the last 7 years he has been included as member in the writing committee of Aortic Diseases Guidelines by ESVS, SICVE, and the European Association Cardio-Thoracic Surgery (EACTS) in conjunction with the Society for Thoracic Surgeons (STS).